EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dopamine-mediated autocrine inhibition of insulin secretion

Edoardo Ferrero, Matilde Masini, Marco Carli, Stefania Moscato, Pascale Beffy, Francesca Vaglini, Letizia Mattii, Alessandro Corti, Marco Scarselli, Michela Novelli, Vincenzo De Tata

Molecular and Cellular Endocrinology · 2024

DOI: 10.1016/j.mce.2024.112294 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2024. Verfasst von Edoardo Ferrero und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Research, Italy. Hauptthemen laut MEDLINE: Insulin, Insulin Secretion, Dopamine, Insulin-Secreting Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of the present research was to explore the mechanisms underlying the role of dopamine in the regulation of insulin secretion in beta cells. The effect of dopamine on insulin secretion was investigated on INS 832/13 cell line upon glucose and other secretagogues stimulation. Results show that dopamine significantly inhibits insulin secretion stimulated by both glucose and other secretagogues, while it has no effect on the basal secretion. This effect requires the presence of dopamine during incubation with the various secretagogues. Both electron microscopy and immunohistochemistry indicate that in beta cells the D2 dopamine receptor is localized within the insulin granules. Blocking dopamine entry into the insulin granules by inhibiting the VMAT2 transporter with tetrabenazine causes a significant increase in ROS production. Our results confirm that dopamine plays an important role in the regulation of insulin secretion by pancreatic beta cells through a regulated and precise compartmentalization mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InsulinInsulin SecretionDopamineInsulin-Secreting CellsGlucoseAutocrine CommunicationVesicular Monoamine Transport ProteinsAnimalsRatsReactive Oxygen SpeciesReceptors, Dopamine D2Cell LineTetrabenazine

Stichwörter der Autor:innen

DopamineInsulin secretionPancreatic beta cellsReactive oxygen species (ROS)

Substanzen

InsulinDopamineGlucoseVesicular Monoamine Transport ProteinsReactive Oxygen SpeciesReceptors, Dopamine D2Slc18a2 protein, ratTetrabenazine

Autor:innen und Institutionen

  • Department of Translational Research, Italy.
  • Department of Clinical and Experimental Medicine, Italy; Interdepartmental Research Centre "Nutraceuticals and Food for Health", Italy.
  • Department of Translational Research, Italy; CIME (Interdepartmental Centre of Electron Microscopy), University of Pisa, Pisa, Italy. Electronic address: vincenzo.detata@med.unipi.it.

Zitieren

APA

Ferrero, E., Masini, M., Carli, M., Moscato, S., Beffy, P., Vaglini, F., Mattii, L., Corti, A., Scarselli, M., Novelli, M., & De Tata, V. (2024). Dopamine-mediated autocrine inhibition of insulin secretion. Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2024.112294

Vancouver

Ferrero E, Masini M, Carli M, Moscato S, Beffy P, Vaglini F, et al. Dopamine-mediated autocrine inhibition of insulin secretion. Molecular and Cellular Endocrinology. 2024. doi:10.1016/j.mce.2024.112294

BibTeX
@article{Ferrero2024,
  author = {Ferrero, Edoardo and Masini, Matilde and Carli, Marco and Moscato, Stefania and Beffy, Pascale and Vaglini, Francesca and Mattii, Letizia and Corti, Alessandro and Scarselli, Marco and Novelli, Michela and De Tata, Vincenzo},
  title = {Dopamine-mediated autocrine inhibition of insulin secretion},
  journal = {Molecular and Cellular Endocrinology},
  year = {2024},
  doi = {10.1016/j.mce.2024.112294}
}
Kostenlos starten →